Bini, Chiara, Andrea Marcellusi, Francesco Saverio Mennini, Silvia Ripoli, Laura Fioravanti, Victoria Federico Paly, Alexa Molinari, Paolo Morelli, Stanimira Krotneva, and Shujun Li. “Cost-Effectiveness of Brentuximab Vedotin Plus Chemotherapy As Frontline Treatment of Stage IV Hodgkin Lymphoma in Italy”. Global and Regional Health Technology Assessment 11, no. 1 (December 10, 2024): 248–257. Accessed January 22, 2025. https://journals.aboutscience.eu/index.php/grhta/article/view/3167.